Triethylenemelamine: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{ | {{DISPLAYTITLE:Triethylenemelamine}} | ||
}} | |||
[[File:Triethylenemelamine.png|thumb|right|Chemical structure of Triethylenemelamine]] | |||
'''Triethylenemelamine''' (TEM) is a chemical compound that belongs to the class of [[alkylating agents]]. It is primarily used in [[chemotherapy]] for its ability to interfere with the growth of [[cancer]] cells. TEM is known for its role in the treatment of various types of [[neoplasms]], particularly in [[hematological malignancies]]. | |||
Triethylenemelamine is a | |||
== | ==Chemical Structure and Properties== | ||
Triethylenemelamine | Triethylenemelamine is a [[heterocyclic compound]] with the molecular formula C<sub>9</sub>H<sub>12</sub>N<sub>6</sub>. It is characterized by a triazine ring structure, which is a six-membered ring containing three carbon atoms and three nitrogen atoms. The presence of ethylene groups attached to the triazine ring is responsible for its alkylating activity. | ||
== | ==Mechanism of Action== | ||
As an alkylating agent, TEM exerts its effects by forming covalent bonds with [[DNA]], leading to cross-linking of DNA strands. This cross-linking inhibits DNA replication and transcription, ultimately resulting in cell cycle arrest and apoptosis of rapidly dividing cells. This mechanism is particularly effective against cancer cells, which have a high rate of division. | |||
==Clinical Uses== | |||
Triethylenemelamine has been used in the treatment of various cancers, including: | |||
* [[Lymphoma]] | |||
* [[Leukemia]] | |||
* [[Ovarian cancer]] | |||
Its use is often limited to specific cases where other treatments have failed or are not suitable. TEM is typically administered as part of a combination chemotherapy regimen to enhance its efficacy and reduce the likelihood of resistance. | |||
==Side Effects== | ==Side Effects== | ||
The use of triethylenemelamine can lead to several side effects, which are common to many alkylating agents. These include: | |||
* [[Myelosuppression]], leading to decreased production of blood cells | |||
* [[Nausea]] and [[vomiting]] | |||
* [[Alopecia]] | |||
* Increased risk of [[secondary malignancies]] | |||
Patients receiving TEM require careful monitoring to manage these adverse effects and to adjust dosages as necessary. | |||
==Related | ==Related pages== | ||
* [[Alkylating agent]] | * [[Alkylating agent]] | ||
* [[Chemotherapy]] | * [[Chemotherapy]] | ||
* [[Cancer treatment]] | * [[Cancer treatment]] | ||
[[Category:Chemotherapy agents]] | |||
[[Category:Alkylating agents]] | [[Category:Alkylating agents]] | ||
[[Category: | [[Category:Heterocyclic compounds]] | ||
Latest revision as of 05:33, 16 February 2025

Triethylenemelamine (TEM) is a chemical compound that belongs to the class of alkylating agents. It is primarily used in chemotherapy for its ability to interfere with the growth of cancer cells. TEM is known for its role in the treatment of various types of neoplasms, particularly in hematological malignancies.
Chemical Structure and Properties[edit]
Triethylenemelamine is a heterocyclic compound with the molecular formula C9H12N6. It is characterized by a triazine ring structure, which is a six-membered ring containing three carbon atoms and three nitrogen atoms. The presence of ethylene groups attached to the triazine ring is responsible for its alkylating activity.
Mechanism of Action[edit]
As an alkylating agent, TEM exerts its effects by forming covalent bonds with DNA, leading to cross-linking of DNA strands. This cross-linking inhibits DNA replication and transcription, ultimately resulting in cell cycle arrest and apoptosis of rapidly dividing cells. This mechanism is particularly effective against cancer cells, which have a high rate of division.
Clinical Uses[edit]
Triethylenemelamine has been used in the treatment of various cancers, including:
Its use is often limited to specific cases where other treatments have failed or are not suitable. TEM is typically administered as part of a combination chemotherapy regimen to enhance its efficacy and reduce the likelihood of resistance.
Side Effects[edit]
The use of triethylenemelamine can lead to several side effects, which are common to many alkylating agents. These include:
- Myelosuppression, leading to decreased production of blood cells
- Nausea and vomiting
- Alopecia
- Increased risk of secondary malignancies
Patients receiving TEM require careful monitoring to manage these adverse effects and to adjust dosages as necessary.